慢病毒介导C3表达对小梁网细胞及眼压的影响
该研究评估慢病毒介导外酶C3转移酶表达对体外培养的原代人小梁网(HTM)细胞及大鼠眼压的影响。结果显示C3表达使HTM细胞发生形态改变,大鼠前房注射LV-C3-GFP后眼压显著降低并至少持续40天,未见明显炎症反应,支持C3基因治疗用于青光眼的可能性。
要点
- 慢病毒介导C3表达使体外培养的HTM细胞发生收缩变圆等形态改变。
- 大鼠前房注射LV-C3-GFP后眼压显著降低,至少持续40天。
- LV-C3-GFP与LV-GFP组均未见明显炎症反应。
核心结论
- 慢病毒介导C3表达可改变培养HTM细胞形态,前房注射LV-C3-GFP使大鼠眼压降低至少40天,未见明显炎症反应,支持C3基因治疗用于青光眼的可能性。
研究设计与样本
- 体外培养原代人小梁网(HTM)细胞,分别用表达GFP的LV-GFP或共表达GFP与C3的LV-C3-GFP处理,评估细胞形态与肌动蛋白应力纤维变化。
- 将载体注射入大鼠前房,用Micron III视网膜成像显微镜在体及荧光显微镜离体观察GFP表达,用回弹式眼压计监测眼压,并用裂隙灯评估眼部。
主要发现
- LV介导的C3表达诱导HTM细胞形态改变,细胞收缩变圆。
- 注射LV-C3-GFP或LV-GFP后第8天至第48天,在大鼠前房角观察到GFP表达。
- 与对侧对照眼(LV-GFP组)或同侧注射前基线相比,LV-C3-GFP组眼压自注射后第3天起显著降低,并至少持续40天(P < 0.05)。
- LV-C3-GFP组和LV-GFP组均未观察到明显炎症体征。
关键数值与推荐
- LV-C3-GFP组大鼠眼压较对侧对照眼或同侧基线显著降低(P < 0.05),自注射后第3天开始并至少持续40天。
- 大鼠前房角GFP表达在体观察时间为注射后第8天至第48天。
临床怎么用
- 该研究提示慢病毒介导C3表达可能作为青光眼基因治疗的一种候选策略,但尚处动物实验阶段,临床转化需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We evaluated the effects of lentivirus-mediated exoenzyme C3 transferase (C3) expression on cultured primary human trabecular meshwork (HTM) cells in vitro, and on rat intraocular pressure (IOP). METHODS: HTM cells were cultured and treated with lentivirus vectors expressing either green fluorescent protein (GFP) only (LV-GFP) or GFP and C3 together (LV-C3-GFP). Changes in cell morphology and actin stress fibers were assessed. The vectors were also injected into the anterior chamber of rats, and GFP expression was visualized by a Micron III Retinal Imaging Microscope in vivo and a fluorescence microscope ex vivo. Changes in rat IOP were monitored by using a rebound tonometer and the eyes were evaluated by slit lamp. RESULTS: LV-mediated C3 expression induced morphologic changes in HTM cells. The cells became retracted and rounded. GFP expression in the anterior chamber angle of rats was observed in vivo from 8 days to 48 days after injection of LV-C3-GFP or LV-GFP. IOP was significantly decreased in the LV-C3-GFP group starting 3 days post injection, and lasting for at least 40 days, when compared to either the contralateral control eyes (the LV-GFP group) or the ipsilateral baseline before injection (P < 0.05). No obvious inflammatory signs were observed in either the LV-C3-GFP or LV-GFP groups. CONCLUSIONS: LV-mediated C3 expression induced changes in morphology of cultured HTM cells. Intracameral injection of LV-C3-GFP lowered rat IOP for at least 40 days. No significant inflammatory reactions were observed in either the LV-C3-GFP or LV-GFP groups. This study supports the possible use of C3 gene therapy for the treatment of glaucoma.
引用
- Tan J, Fan N, Wang N, et al. Effects of Lentivirus-Mediated C3 Expression on Trabecular Meshwork Cells and Intraocular Pressure. Invest Ophthalmol Vis Sci. 2018. PMID: 30326062. doi:10.1167/iovs.18-24978
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。